The Future of Hypoparathyroidism Treatment Market: By 2023 to 2033 Outlook

 

The global hypoparathyroidism treatment market is on the verge of significant expansion, according to a comprehensive market analysis conducted by Future Market Insights. The market, valued at US$ 777.4 million in 2022, is projected to reach an estimated US$ 841.9 million by the close of 2023. Furthermore, the analysis anticipates a steady Compound Annual Growth Rate (CAGR) of 7.7% from 2023 through 2033, culminating in a projected market value of US$ 1,767.4 million at the end of the forecast period.

Hypoparathyroidism, a rare endocrine disorder characterized by insufficient levels of parathyroid hormone, is identified as a primary catalyst for the escalating demand for innovative treatment modalities. This significant market expansion underscores the growing focus on advancing therapeutic interventions to address the unmet medical needs of individuals affected by this condition.

Get your Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-7857

"The forecasted growth of the global hypoparathyroidism treatment market reflects the increasing recognition of the challenges faced by patients and healthcare providers in managing this rare disorder," said a spokesperson from Future Market Insights. "As awareness grows and technology continues to evolve, there is a heightened demand for effective and patient-centric treatment options."

The market analysis conducted by Future Market Insights indicates a robust trajectory for the hypoparathyroidism treatment industry, propelled by ongoing efforts to develop effective and patient-centric solutions. The remarkable growth underscores the industry's commitment to addressing the unique challenges posed by hypoparathyroidism and improving the quality of life for those affected.

As the hypoparathyroidism treatment industry continues its upward trajectory, stakeholders, including pharmaceutical companies, healthcare professionals, and researchers, are encouraged to collaborate and innovate in the pursuit of groundbreaking solutions. This growth not only represents a significant market opportunity but also signifies a collective commitment to improving the lives of those grappling with this rare endocrine disorder.

Key Takeaways:

  • Over the next several decades, the Indian market is expected to grow at an 8.6% CAGR.
  • By 2033, the worldwide market is expected to be worth US$ 1767.4 million.
  • The United States has emerged as the dominant market, accounting for more than 37.7% of overall demand in 2022.
  • Over the next several decades, the Chinese market is expected to grow at a CAGR of 7.9%.
  • In 2022, the calcium supplements category accounted for 38.29% of market revenue.

Competitive Landscape:

  • Amolyt Pharma revealed an oral presentation at the 25th European Congress of Endocrinology (ECE) 2023 in May 2023. The presentation highlights the potential benefits of eneboparatide as a treatment for hypoparathyroidism, an illness in which numerous individuals have or are at risk of developing osteopenia and osteoporosis.
  • In November 2022, the Food and Drug Administration (FDA) authorized for Priority Assessment a new drug application (NDA) for TransConTM PTH (palopegteriparatide) in adults with hypoparathyroidism.

Key Companies Profiled:

  • Takeda Pharmaceutical Company Limited.
  • Entera Bio Ltd.
  • Amgen Inc.
  • Ascendis Pharma A/S
  • F. Hoffmann-La Roche Ltd
  • ProLynx, Inc.
  • Extend Biosciences, Inc.
  • BionPharma Inc.
  • Teva Pharmaceuticals Ltd.

Hypoparathyroidism Treatment Market Segmentation:

By Product Type:

  • Parathyroid Hormone
    • Natpara
    • Others
  • Vitamin D Analogue
    • Vitamin D2
    • Vitamin D3
  • Calcium Supplements

By Route of Administration:

  • Oral
  • Parenteral

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Comments

Post a Comment

Popular posts from this blog

Beyond COVID-19: A Look at Vaccines Market Post-Pandemic From 2023 to 2033

Image
 In recent years, the Vaccines Market has undergone a dramatic transition brought on by ground-breaking scientific discoveries and the pressing need for universal immunisation. The COVID-19 pandemic acted as a stimulus for a surge in vaccine demand that has prompted academics and pharmaceutical corporations to develop at a previously unheard-of rate. This blog examines the changing market environment for vaccines, highlighting significant trends, difficulties, and opportunities. Technology advancements like mRNA and vector-based platforms have completely changed how vaccines are developed. These innovative techniques have proven to be remarkably effective against contagious illnesses like COVID-19, opening the door for the development of new vaccines. In response to the pandemic, mRNA vaccines were developed and distributed quickly, showcasing the promise of these ground-breaking technology. Supercharge Your Knowledge: Dive into the Booming Vaccines market with Our Sample Report @ ht
Read more

Key Players Shaping the 3D Cell Culture Market: By 2022 to 2031

Image
  The global 3D cell culture market is anticipated to account for a growth rate of around 9.8% over the forecast period from 2022 to 2031. The global market is expected to account for around US$ 1.15 Billion in 2022 and attain a valuation of US$ 2.67 Billion by 2031. According to the analysis done by Future Market Insights, the global 3D cell culture market accounted for a CAGR of 4.8% in 2021. During the historical period of 2016 to 2021, the 3D cell culture market expanded at a CAGR of 7.1%. According to the studies conducted by Future Market Insights, the comparative analysis along with the market growth rate of the global 3D cell culture market is expected to show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 10 BPS, However, a positive BPS growth is expected in H1-2022 over H1- 2021 duration with 02 Basis Point Share (BPS). The global 3D cell culture market observes a drop in the BPS values owned to its disadvantage as compared to surface
Read more

Technological Advancements Fueling the Physiotherapy Equipment Market By 2023 to 2033

 The physical well-being and quality of life of people who are recuperating from injuries or who have chronic diseases are greatly enhanced by physical therapy. The Physiotherapy Equipment Market has experienced growth in tandem with the increase in demand for physiotherapy services. Due in large part to technological innovation, the prevalence of neurological and musculoskeletal illnesses is rising, and this sector of the economy is expanding quickly. The market for physiotherapy equipment has a large selection of gadgets and instruments made to help with the healing process. The industry has made considerable strides to meet a variety of treatment demands, from heat and cold therapy devices to electrotherapy machines and therapeutic exercise equipment. These contemporary resources help physiotherapists deliver more focused care, increase patient results, and enrich the therapeutic process as a whole. Grab Your Exclusive Report: Unveiling the Spectacular Growth of the Physiotherapy E
Read more